Source: ScienceBoard
Transcription factors (proteins that control gene expression) can be used in simple "recipes" to easily convert stem cells into hundreds of different cells and tissues, according to a new study published in Nature Biotechnology on November 30.
Source: News Medical.Net
Over the past decades, stem cells are being broadly used as regenerative medicine for repairing or replacing tissues that are damaged due to injury or diseases. With the advancement in stem cell therapy, scientists have now engineered stem cells that can effectively treat metastatic bone cancer without damaging surrounding normal tissues.
Source: Stem Cells Portal
Stem cells are considered one of the most promising tools in the field of regenerative medicine because they are a cell type that can give rise to all the cells in our bodies and that has the potential to be used to treat tissue loss due to damage or disease.
Source: Geneng News
Stem cells hold so much potential for regenerative medicine, it is understandable that so many people should be so impatient to see all that potential realized. But people, the desperately ill among them, need to recognize that stem cells aren’t talismans.
Source: Stem Cells Portal
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have developed a novel microcarrier for large-scale cell production and expansion that offers higher yield and cost-effectiveness compared to traditional methods.
Source: Phys.org
One of the ways cells in developing organisms keep track of where they are and what they are supposed to be doing is through a type of chemical signal called a morphogen. Lim's synthetic biology team at UCSF and a pair of research groups at the Francis Crick Institute in London—led by Guillaume Salbreux, Ph.D., and Jean-Paul Vincent, Ph.D. independently took the innovative approach of engineering a synthetic morphogen from the ground up.
Source: BioWorld
Regenerative therapies startup Jointechlabs Inc. has won the U.S. FDA’s nod for its MiniTC point-of-care fat tissue processing device. The 510(k)-cleared product is designed to extract microfat for use in grafts for a variety of indications, including medical aesthetics, plastic surgery, orthobiologics and wound healing.